Endocrinologic Diseases in Pediatric Cardiac Intensive Care

Carmen L Soto-Rivera1, Steven M Schwartz, Jaclyn E Sawyer

  • 11Department of Pediatrics, Section of Endocrinology, Harvard Medical School, Boston Children's Hospital, Boston, MA. 2Department of Pediatrics, Section of Critical Care Medicine and Cardiology, Section of Cardiac Critical Care Medicine, University of Toronto, The Hospital for Sick Children, Toronto, ON, Canada. 3Division of Pharmacy, Cincinnati Children's Hospital Medical Center, Cincinnati, OH. 4Pediatric Critical Care, Royal Brompton Hospital, London, United Kingdom. 5Division of Medicine Critical Care, Department of Pediatrics, Harvard Medical School, Boston Children's Hospital, Boston, MA.

Insights

This review covers hyperglycemia and thyroid/adrenal issues in children undergoing cardiac surgery. Understanding these endocrine and metabolic disturbances is crucial for patient management.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Surgery
  • Critical Care Medicine

Background:

  • Endocrine and metabolic dysfunctions are prevalent in critically ill children with cardiac disease.
  • Children undergoing complex congenital heart disease surgery are particularly susceptible to these issues.
  • Understanding pathophysiology, clinical impact, and treatment is vital for managing these high-risk patients.

Purpose of the Study:

  • To review the pathophysiology of hyperglycemia, and thyroid and adrenal dysfunction in pediatric cardiac surgery patients.
  • To discuss the clinical impact of these endocrine disturbances.
  • To outline current treatment strategies for these conditions.

Main Methods:

  • Literature review of MEDLINE and PubMed databases.
  • Synthesis of existing research on glucose metabolism, thyroid, and adrenal function.
  • Analysis of clinical implications and therapeutic approaches.

Main Results:

  • Hyperglycemia is a common complication.
  • Thyroid and adrenal function can be significantly altered.
  • These disturbances impact patient outcomes and recovery.

Conclusions:

  • Endocrine and metabolic disturbances are significant concerns in pediatric cardiac surgery.
  • Effective management requires a thorough understanding of the underlying pathophysiology and clinical impact.
  • Targeted treatment strategies are essential for optimizing care and improving outcomes.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
716
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
3.7K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
880
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
584
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312